[Early appearance of myelodysplastic syndrome secondary to therapy for Burkitt-type acute lymphoblastic leukemia (ALL3)]

Sangre (Barc). 1999 Feb;44(1):81-2.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects
  • Burkitt Lymphoma / complications
  • Burkitt Lymphoma / drug therapy*
  • Fatal Outcome
  • Humans
  • Male
  • Myelodysplastic Syndromes / etiology*
  • Prognosis
  • Time Factors

Substances

  • Antineoplastic Agents